News
1 minute read

MBHB Partner Kevin Noonan Quoted in Benzinga Article Entitled, "Merck's Idenix Deal Could Deliver Bad News For Gilead Sciences"

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in a June 16, 2014 Benzinga.com article entitled, “Merck’s Idenix Deal Could Deliver Bad News For Gilead Sciences.”  View the article